Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha-carotene is a provitamin A carotenoid found in various fruits and vegetables. It is structurally similar to beta-carotene but contains a beta- and an epsilon-ring at opposite ends of its molecule. As a provitamin A compound, alpha-carotene can be converted by the body into vitamin A, which plays essential roles in immune function, cellular communication, growth and development, and reproduction[1][3][4]. Higher serum concentrations of alpha-carotene have been associated with lower risks of cancer and all-cause mortality[5]. Mechanistically, alpha-carotene has demonstrated anti-metastatic properties in preclinical studies by inhibiting integrin β1-mediated phosphorylation of focal adhesion kinase (FAK), thereby reducing MAPK pathway activation; it also suppressed lung metastasis when combined with taxol in animal models[5]. Alpha-carotene acts as an antioxidant and plant metabolite.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-carotene.